TargetSerine/threonine-protein kinase Chk2(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 28nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 32nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 38nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 42nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 44nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 44nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 52nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 56nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 57nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 62nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 64nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 67nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 75nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 85nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 107nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 137nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase Chk2(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 145nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 147nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Valeant Pharmaceuticals Research & Development
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of MEK-1 activityMore data for this Ligand-Target Pair